Allan E. Rubenstein, MD

Clinical Professor, Department of Neurology

Clinical Professor, Department of Pediatrics

Positions

Clinical Professor, Department of Neurology at NYU Grossman School of Medicine

Clinical Professor, Department of Pediatrics at NYU Grossman School of Medicine

Graduate Education

MD from Tufts University

Phone

212-263-9695

Is this your profile?
Edit profile

Clinical assessment of the use of topical liquid diclofenac following laser microporation of cutaneous neurofibromas in individuals with neurofibromatosis type 1

undefined...

Heliyon. 2021 Mar; 7(3):e06518

Determination of Vitamin D Levels in Patients With Neurofibromatosis Type 1 in the Pediatric Age Group

undefined...

Clinical pathology (Thousand Oaks, Ventura County, Calif.). 2020; 13:

A novel small molecule HSP90 inhibitor, NXD30001, differentially induces heat shock proteins in nervous tissue in culture and in vivo

undefined...

Cell stress chaperones. 2014 May; 19(3):421-35

Erratum: A novel small molecule HSP90 inhibitor, NXD30001, differentially induces heat shock proteins in nervous tissue in culture and in vivo (Cell Stress and Chaperones DOI 10.1007/s12192-013-0467-2)

undefined...

Cell stress chaperones. 2014; 19(3):437

Therapeutic Potential of HSP90 Inhibition for Neurofibromatosis Type 2

undefined...

Clinical cancer research. 2013 Jul 15; 19(14):3856-70

The novel Hsp90 inhibitor NXD30001 induces tumor regression in a genetically engineered mouse model of glioblastoma multiforme

undefined...

Molecular cancer therapeutics. 2010 Sep; 9(9):2618-26

Consensus recommendations to accelerate clinical trials for neurofibromatosis type 2

undefined...

Clinical cancer research. 2009 Aug 15; 15(16):5032-5039

Synthesis of pochoxime prodrugs as potent HSP90 inhibitors

undefined...

Bioorganic & medicinal chemistry letters. 2009 Jul 15; 19(14):3836-40

See All Publications (100)